4hon MSN
Ovarian cancer cells surprise scientists—the body's own defense may be the key to longer survival
A new study sheds light on why some patients with the most aggressive form of ovarian cancer respond better to treatment than others. Tumors positive for a molecule called MHC class II are linked to ...
News-Medical.Net on MSN
MHC class II marks stronger immune response and longer survival in ovarian cancer
A new study sheds light on why some patients with the most aggressive form of ovarian cancer respond better to treatment than others. Tumors positive for a molecule called MHC class II are linked to ...
A small study suggests Mavenclad’s effectiveness in MS may be linked to how regulatory T-cells respond to treatment.
When running a fever during infection, we often feel chills, which prompt us to take action to warm ourselves, such as ...
Scientists have uncovered a surprising way tumors turn the immune system to their advantage. Researchers at the University of ...
A Nature Medicine study links the activation of brain reward pathways to stronger antibody responses after hepatitis B vaccination in healthy adults.
Are you struggling to conceive despite trying everything The secret might lie in your immune system A fertility expert shares how an overactive immune system can prevent implantation and what you can ...
New therapy reprograms immune cells inside tumors to attack cancer, bypassing traditional cell therapy manufacturing ...
Then you get into the breads made for people with dietary restrictions, such as gluten-free bread. But even if you don’t have ...
A detailed analysis of immune cells in Long COVID patients has revealed a previously unknown molecular signature linked to ...
New research suggests that Epstein-Barr virus may actively provoke the immune system in people with multiple sclerosis. Scientists found large buildups of virus-targeting immune cells in the nervous ...
News-Medical.Net on MSN
Ride Cincinnati grant funds research on immune activating wafer for glioblastoma treatment
A multidisciplinary team of University of Cincinnati Cancer Center researchers has received a $40,000 Ride Cincinnati grant to study a delayed release preparation, or wafer, of an immunostimulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results